Alex Chiu, MD, MBA, FACEP
President
Dr. Chiu is a board-certified emergency physician and telemedicine provider who is dedicated to creating solutions where emergency medicine and telemedicine overlap. In addition to clinical care, he oversees the Telemedicine911 software company and the Air MD telehealth control center.
He led a team to build the FDA cleared CardiacLinx mobile 12-lead ECG platform and oversees evidence-based medical operation protocol development for Ross Medical Corporation, which was published as some of the first cases of Hospital At Home cardiac management. Dr. Chiu was chairman of the Mobile Health SIG and Technology SIG for the American Telemedicine Association for more than 6 years and has contributed to documents for emergency and psychiatric care coordination over telehealth. He was the counselor of the telehealth section at the American College of Emergency Physicians and led teams improving emergency telehealth research and support for telehealth and 911. He led an advocacy team to help introduce a bill for emergencies during telemedicine. He is the founder and executive director of the not-for-profit organization The Ross Health Foundation, a group of doctors and logisticians dedicated to the fundraising and implementation efforts for international medical missions.
Previously, he designed robotics at the Stanford Genome Technology Center for high throughput gene deletion and was a synthetic chemist at Celera designing anti-cancer drugs. He received an MD from SUNY Downstate College of Medicine in Brooklyn, NY, an MBA from the University of Southern California Marshall School of Business, and a BS in Chemistry from the University of California, Santa Barbara. He completed his emergency medicine specialty training at the University of Medicine and Dentistry of New Jersey, University Hospital, a Level 1 trauma and cardiac center, is a Fellow of the American College of Emergency Physicians, and is a diplomat of the American Board of Emergency Medicine.
Previously, he designed robotics at the Stanford Genome Technology Center for high throughput gene deletion and was a synthetic chemist at Celera designing anti-cancer drugs. He received an MD from SUNY Downstate College of Medicine in Brooklyn, NY, an MBA from the University of Southern California Marshall School of Business, and a BS in Chemistry from the University of California, Santa Barbara. He completed his emergency medicine specialty training at the University of Medicine and Dentistry of New Jersey, University Hospital, a Level 1 trauma and cardiac center, is a Fellow of the American College of Emergency Physicians, and is a diplomat of the American Board of Emergency Medicine.
